These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 8452962)

  • 21. Induction of secretory immunity and memory at mucosal surfaces.
    Brandtzaeg P
    Vaccine; 2007 Jul; 25(30):5467-84. PubMed ID: 17227687
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of specific immunity at mucosal surfaces: prospects for vaccine development.
    Czerkinsky C; Quiding M; Eriksson K; Nordström I; Lakew M; Wenerås C; Kilander A; Björck S; Svennerholm AM; Butcher E
    Adv Exp Med Biol; 1995; 371B():1409-16. PubMed ID: 7502829
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New generation of mucosal adjuvants for the induction of protective immunity.
    Yuki Y; Kiyono H
    Rev Med Virol; 2003; 13(5):293-310. PubMed ID: 12931340
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New approaches to mucosal immunization.
    Langermann S
    Semin Gastrointest Dis; 1996 Jan; 7(1):12-8. PubMed ID: 8903575
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Intestinal mucosa immunity and oral vaccines especially regarding E. coli vaccines: a review].
    Aiuti F; Iebba F
    Infez Med; 2002 Dec; 10(4):191-203. PubMed ID: 12754425
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New insights in mucosal vaccine development.
    Pavot V; Rochereau N; Genin C; Verrier B; Paul S
    Vaccine; 2012 Jan; 30(2):142-54. PubMed ID: 22085556
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intramuscular delivery of a cholera DNA vaccine primes both systemic and mucosal protective antibody responses against cholera.
    Xu G; Wang S; Zhuang L; Hackett A; Gu L; Zhang L; Zhang C; Wang H; Huang Z; Lu S
    Vaccine; 2009 Jun; 27(29):3821-30. PubMed ID: 19443090
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mucosal antitoxic and antibacterial immunity after cholera disease and after immunization with a combined B subunit-whole cell vaccine.
    Svennerholm AM; Jertborn M; Gothefors L; Karim AM; Sack DA; Holmgren J
    J Infect Dis; 1984 Jun; 149(6):884-93. PubMed ID: 6736680
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA.
    Holmgren J; Adamsson J; Anjuère F; Clemens J; Czerkinsky C; Eriksson K; Flach CF; George-Chandy A; Harandi AM; Lebens M; Lehner T; Lindblad M; Nygren E; Raghavan S; Sanchez J; Stanford M; Sun JB; Svennerholm AM; Tengvall S
    Immunol Lett; 2005 Mar; 97(2):181-8. PubMed ID: 15752556
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impaired immune response to natural infection as a correlate of vaccine failure in a field trial of killed oral cholera vaccines.
    Clemens J; Rao M; Sack D; Ahmed F; Khan MR; Chakraborty J; Kay B; Huda S; Yunus M; van Loon F
    Am J Epidemiol; 1995 Oct; 142(7):759-64. PubMed ID: 7572947
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Designing oral vaccines targeting intestinal dendritic cells.
    Devriendt B; De Geest BG; Cox E
    Expert Opin Drug Deliv; 2011 Apr; 8(4):467-83. PubMed ID: 21375470
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current status of an oral B subunit whole cell cholera vaccine.
    Svennerholm AM; Jertborn M; Gothefors L; Karim A; Sack DA; Holmgren J
    Dev Biol Stand; 1983; 53():73-9. PubMed ID: 6873479
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protein energy malnutrition alters mucosal IgA responses and reduces mucosal vaccine efficacy in mice.
    Rho S; Kim H; Shim SH; Lee SY; Kim MJ; Yang BG; Jang MH; Han BW; Song MK; Czerkinsky C; Kim JO
    Immunol Lett; 2017 Oct; 190():247-256. PubMed ID: 28860040
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Per-oral immunization with antigen-conjugated nanoparticles followed by sub-cutaneous boosting immunization induces long-lasting mucosal and systemic antibody responses in mice.
    Howe SE; Konjufca VH
    PLoS One; 2015; 10(2):e0118067. PubMed ID: 25710518
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mucosal Lactobacillus vectored vaccines.
    Yu Q; Zhu L; Kang H; Yang Q
    Hum Vaccin Immunother; 2013 Apr; 9(4):805-7. PubMed ID: 23322214
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inflammatory cytokines and antigen presenting cell activation.
    Murtaugh MP; Foss DL
    Vet Immunol Immunopathol; 2002 Sep; 87(3-4):109-21. PubMed ID: 12072225
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral immunization: an update.
    Mestecky J; Nguyen H; Czerkinsky C; Kiyono H
    Curr Opin Gastroenterol; 2008 Nov; 24(6):713-9. PubMed ID: 19122521
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral administration of cholera toxin-Sendai virus conjugate potentiates gut and respiratory immunity against Sendai virus.
    Liang XP; Lamm ME; Nedrud JG
    J Immunol; 1988 Sep; 141(5):1495-501. PubMed ID: 2842395
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mucosal and systemic responses of immunogenic vaccines candidates against enteric Escherichia coli infections in ruminants: A review.
    Lawan A; Jesse FFA; Idris UH; Odhah MN; Arsalan M; Muhammad NA; Bhutto KR; Peter ID; Abraham GA; Wahid AH; Mohd-Azmi ML; Zamri-Saad M
    Microb Pathog; 2018 Apr; 117():175-183. PubMed ID: 29471137
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mucosal immunity: overcoming the barrier for induction of proximal responses.
    McKenzie BS; Brady JL; Lew AM
    Immunol Res; 2004; 30(1):35-71. PubMed ID: 15258310
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.